Address.jpg (Address)
Finasteride Tablet, Film Coated
Product Images NDC 50090-1936
8 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 50090-1936). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Address3.jpg (Address3)
Figure1.jpg (Figure1)
A line graph comparing mean change from baseline over four years between Finasteride and placebo groups. The Y-axis shows mean change values, and the X-axis shows time from baseline through Year 4. Two distinct lines represent Finasteride and placebo with Finasteride showing a greater decrease over time.*
Figure2.jpg (Figure2)
A line graph titled 'Figure 2 Percent of Patients Having Surgery for BPH, Including TURP' comparing Finasteride and placebo groups over 48 months. The y-axis shows the percent of patients, and the x-axis shows observation time in months. The Finasteride group consistently shows a lower cumulative percentage of patients undergoing surgery compared to the placebo group.*
Figure3.jpg (Figure3)
A line graph showing the mean percent change from baseline over four years for placebo and Finasteride groups. The x-axis represents time points from baseline to year 4, while the y-axis denotes mean percent change with error bars. Two lines display data for placebo and Finasteride, with the Finasteride group showing a sustained negative percent change and the placebo group showing an increasing positive percent change over time.*
Figure4.jpg (Figure4)
A Kaplan-Meier survival curve chart depicting the percentage with event over time in years from randomization for four groups: Placebo, Finasteride, Doxazosin, and Combination. The x-axis shows years from 0 to 5.5, and the y-axis shows percent with event from 0 to 25. Placebo shows the highest event rate, followed by Finasteride, Doxazosin, and Combination with the lowest event rate.*
Label Image (Lbl500901936)
Label for Finasteride 5 mg film-coated tablets by A-S Medication Solutions. The label indicates a package of 90 tablets, oral route, to be stored at 68-77 degrees Fahrenheit and protected from moisture. It includes dosage and storage instructions and the product NDC 50090-1936-1.*
Structure.jpg (Structure)
Chemical structure of Finasteride, a steroid-like molecular structure with multiple ring systems and functional groups including amide and ketone moieties, depicted as a line-angle diagram.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
